3M Company (NYSE:MMM) entered into a definitive agreement to acquire Ivera Medical Corporation on February 19, 2015. Ivera Medical Corporation has annual sales of $30 million. Subject to customary closing conditions and regulatory approvals, the transaction is expected to close in the first half of 2015. The transaction is expected to be neutral to earnings in the first 12 months following completion of the transaction. Houlihan Lokey acted as financial advisor to Ivera Medical. As of March 6, 2015, the transaction received approval from FTC.

3M Company (NYSE:MMM) completed the acquisition of Ivera Medical Corporation March 13, 2015. The business is now a wholly owned subsidiary of 3M and a part of its Critical & Chronic Care Solutions Division.